Odile Leroy

3.2k total citations
51 papers, 1.7k citations indexed

About

Odile Leroy is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Odile Leroy has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Public Health, Environmental and Occupational Health and 11 papers in Immunology. Recurrent topics in Odile Leroy's work include Malaria Research and Control (18 papers), Mosquito-borne diseases and control (14 papers) and Pneumonia and Respiratory Infections (11 papers). Odile Leroy is often cited by papers focused on Malaria Research and Control (18 papers), Mosquito-borne diseases and control (14 papers) and Pneumonia and Respiratory Infections (11 papers). Odile Leroy collaborates with scholars based in France, Germany and United States. Odile Leroy's co-authors include Juhani Eskola, Ron Dagan, Helena Käyhty, Michel Garenne, Claude Leclerc, Heidi Åhman, Pablo Yagupsky, Rimma Melamed, Tomi Wuorimaa and Giampietro Corradin and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Epidemiology.

In The Last Decade

Odile Leroy

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Odile Leroy France 22 887 542 497 347 226 51 1.7k
Amanda Leach United Kingdom 16 1.1k 1.2× 541 1.0× 573 1.2× 153 0.4× 174 0.8× 22 1.8k
Birgitte Giersing Switzerland 25 636 0.7× 502 0.9× 205 0.4× 304 0.9× 345 1.5× 77 2.0k
Serign J. Ceesay Gambia 18 450 0.5× 706 1.3× 266 0.5× 342 1.0× 56 0.2× 23 1.5k
Annie‐Claude Labbé Canada 31 1.2k 1.3× 309 0.6× 316 0.6× 239 0.7× 112 0.5× 114 2.5k
Lawrence Yamuah Ethiopia 22 785 0.9× 724 1.3× 65 0.1× 214 0.6× 244 1.1× 50 1.8k
Bruce D. Gaynor United States 29 1.0k 1.1× 362 0.7× 1.1k 2.2× 244 0.7× 141 0.6× 74 2.2k
Robert G. Sharrar United States 16 771 0.9× 160 0.3× 80 0.2× 302 0.9× 549 2.4× 25 2.3k
Svein Arne Nordbø Norway 24 908 1.0× 145 0.3× 238 0.5× 128 0.4× 86 0.4× 83 1.7k
Annette Jepson United Kingdom 24 479 0.5× 574 1.1× 55 0.1× 472 1.4× 123 0.5× 38 1.7k
Philippe Minodier France 23 691 0.8× 1.1k 2.1× 69 0.1× 131 0.4× 174 0.8× 98 2.0k

Countries citing papers authored by Odile Leroy

Since Specialization
Citations

This map shows the geographic impact of Odile Leroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Odile Leroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Odile Leroy more than expected).

Fields of papers citing papers by Odile Leroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Odile Leroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Odile Leroy. The network helps show where Odile Leroy may publish in the future.

Co-authorship network of co-authors of Odile Leroy

This figure shows the co-authorship network connecting the top 25 collaborators of Odile Leroy. A scholar is included among the top collaborators of Odile Leroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Odile Leroy. Odile Leroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bougouma, Edith C., Nirianne Palacpac, Alfred B. Tiono, et al.. (2022). Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children. Frontiers in Immunology. 13. 978591–978591. 7 indexed citations
2.
Arisue, Nobuko, Nirianne Palacpac, Edward Hosea Ntege, et al.. (2022). African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination. Frontiers in Cellular and Infection Microbiology. 12. 1058081–1058081. 2 indexed citations
3.
Medaglini, Donata, et al.. (2018). Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow. Vaccine. 36(9). 1136–1145. 14 indexed citations
4.
Murphy, Sean C., Cornelus C. Hermsen, Alexander D. Douglas, et al.. (2014). External Quality Assurance of Malaria Nucleic Acid Testing for Clinical Trials and Eradication Surveillance. PLoS ONE. 9(5). e97398–e97398. 22 indexed citations
5.
Leroy, Odile, et al.. (2014). Roadmap for the establishment of a European vaccine R&D infrastructure. Vaccine. 32(51). 7021–7024. 6 indexed citations
6.
Imoukhuede, Egeruan B., Nathalie Imbault, Marita Troye‐Blomberg, et al.. (2011). European Vaccine Initiative: lessons from developing malaria vaccines. Expert Review of Vaccines. 10(12). 1697–1708. 12 indexed citations
7.
Imoukhuede, Egeruan B., et al.. (2010). European malaria vaccine initiative: Portfolio and perspectives for the future. Human Vaccines. 6(1). 146–150. 2 indexed citations
8.
Nébié, Issa, Amidou Diarra, Alphonse Ouédraogo, et al.. (2009). Humoral and cell‐mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso. Parasite Immunology. 31(8). 474–480. 15 indexed citations
9.
Craig, Alister, Anthony A. Holder, Odile Leroy, & Roland Ventura. (2009). Malaria vaccines – how and when to proceed?. Trends in Parasitology. 25(12). 535–537. 2 indexed citations
10.
Esen, Meral, Peter G. Kremsner, Regina Schleucher, et al.. (2009). Safety and immunogenicity of GMZ2 — a MSP3–GLURP fusion protein malaria vaccine candidate. Vaccine. 27(49). 6862–6868. 83 indexed citations
11.
Hermsen, Cornelus C., Denise Telgt, Karina Teelen, et al.. (2006). Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. Vaccine. 25(15). 2930–2940. 68 indexed citations
12.
Puumalainen, Taneli, Helena Käyhty, Marilla Lucero, et al.. (2002). Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants. The Pediatric Infectious Disease Journal. 21(4). 309–314. 33 indexed citations
13.
Sigurdardottir, Sigurveig, Þórólfur Guðnason, Sveinn Kjartansson, et al.. (2002). Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine. The Pediatric Infectious Disease Journal. 21(6). 548–554. 22 indexed citations
14.
Wuorimaa, Tomi, Helena Käyhty, Odile Leroy, & Juhani Eskola. (2001). Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults. Vaccine. 19(15-16). 1863–1869. 47 indexed citations
15.
Ölander, Rose‐Marie, Tomi Wuorimaa, Helena Käyhty, et al.. (2001). Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers. Vaccine. 20(3-4). 336–341. 19 indexed citations
16.
17.
Åhman, Heidi, et al.. (1998). Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. The Pediatric Infectious Disease Journal. 17(3). 211–216. 108 indexed citations
18.
Dagan, Ron, et al.. (1996). Reduction of pneumococcal nasopharyngeal carriage after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid in early infancy. 36. 150. 1 indexed citations
19.
Leroy, Odile & Michel Garenne. (1991). Risk Factors of Neonatal Tetanus in Senegal. International Journal of Epidemiology. 20(2). 521–526. 19 indexed citations
20.
Garenne, Michel, et al.. (1991). Child mortality after high-titre measles vaccines: prospective study in Senegal. The Lancet. 338(8772). 903–907. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Leach Breakdown of academic impact, for papers by Birgitte Giersing Breakdown of academic impact, for papers by Serign J. Ceesay Breakdown of academic impact, for papers by Annie‐Claude Labbé Breakdown of academic impact, for papers by Lawrence Yamuah Breakdown of academic impact, for papers by Bruce D. Gaynor Breakdown of academic impact, for papers by Robert G. Sharrar Breakdown of academic impact, for papers by Svein Arne Nordbø Breakdown of academic impact, for papers by Annette Jepson Breakdown of academic impact, for papers by Philippe Minodier
Rankless by CCL
2026